Thomas Yau
102 Pokfulam Road
Hong Kong, China
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study.
Journal: Advances in therapy
Published: September 25, 2024
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
Journal: The lancet. Gastroenterology & hepatology
Published: October 02, 2023
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 26, 2021
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients.
Journal: Investigational new drugs
Published: July 14, 2021
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.
Journal: Advances in therapy
Published: March 28, 2021
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: December 26, 2020
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: October 22, 2020
Novel systemic therapy for hepatocellular carcinoma.
Journal: Hepatology international
Published: April 01, 2020
Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552].
Journal: Journal of hepatology
Published: November 01, 2019
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.
Journal: Journal of hepatology
Published: November 06, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026